Articles liés à Chronic Myeloid Leukemia
Synopsis
Cytogenetics of CML.- The biology and pathogenesis of CML.- The choice of 1st line CML‐treatment.- A review and up‐date of the European LeukemiaNet recommendations for the management of CML.- Management of adverse events associated with ATP‐competitive BCR‐ABL 1 tyrosine kinase inhibitors in CML.- Standardization of molecular monitoring for CML.- Epidemiology of CML.- Prognostic scores for patients with CML under particular consideration of disease specific death.- Response‐related predictors of survival.- CML‐ blast crisis: implications and management.- Chronic Myeloid Leukemia and Pregnancy.- The role of hematopoietic stem cell transplantation in CML.- Discontinuation or cessation of tyrosine kinase inhibitor treatment in CML patients with deep molecular response.- The interferon‐alpha revival in CML.- Changing the cost of care for CML: the availability of generic imatinib.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
